Analysts Skeptical About Ability Of Korean Government To Draw Investors To Risky R&D Fund
This article was originally published in PharmAsia News
Executive Summary
SEOUL - Investors and analysts are voicing skepticism about the Korean government's ability to successfully draw enough investors into a KRW2 trillion ($1.7 billion) R&D fund to help local companies develop innovative new drugs